Table 7

Adherence and cost (in US$ (2005)) for most recent treatment

Regime (Recommended duration)

% achieving recommended durations (n)

Median cost in US$ (range)

Artesunate + Mefloquine (3 days)

77% (34/44)

0.77 (0 – 12.82)

Artemisinin derivative + other antimalarial (7 days)

13% (4/31)

1.67 (0.22 – 38.90)

Artemisinin alone* (7 days)

28% (8/29)

2.05 (0.38 – 26.70)

Quinine + tetracycline (+/- other antimalarial) (7 days)

0% (0/13)

1.11 (0.35 – 17.3)

Quinine (+/- other antimalarial) (7 days)

13% (3/24)

0.66 (0 – 11.10)

Chloroquine (+/- other antimalarial) (3 days)

35% (22/63)

0.67 (0.11–11.11)

Unknown

-

3.59 (0 – 41.03)

* Based on studies of artesunate monotherapy [41-43].

Yeung et al. Malaria Journal 2008 7:96   doi:10.1186/1475-2875-7-96